SEMRHI Receives Award Recognitions For THREE American Heart Association Programs!

October 9, 2026

SEMRHI is proud to announce that we have received three American Heart Association recognitions: 2026 Gold Recognition for the Target: Type 2 Diabetes℠ program, 2026 GOLD Recognition for the Check. Change. Control. Cholesterol™ program, and 2026 SILVER+Recognition for the Target: BP™ program.

These prestigious recognitions highlight SEMRHI’s commitment to evidence-based practices that support accurate blood pressure measurement, improve care for patients with type 2 diabetes and cardiovascular risk factors, and increase cholesterol awareness, detection, and management through evidence-based care and patient education.

Congratulations to our entire SEMRHI team for helping make these achievements possible!